trial with title COMMANDS - Myelodysplastic Syndromes (MDS) - ACE536-MDS-002 - Australia

Find a participating research site

If you are interested in taking part in this study, begin typing your post code below and then select from the dropdown list. The map will update with sites within the distance you select with a list of locations below.

Please note the map below only lists study sites that are accepting online referrals. If you cannot find a site in your area please check back again as study sites can be added to the study on an ongoing basis.

Select Country

Site Name Address Status Distance
Blacktown Hospital
Blacktown Road
Blacktown, , 2148
Australia
Not Recruiting --
Cabrini Hospital
183 Wattletree Road Malvern
Malvern, , 3144
Australia
Recruiting -- Am I Eligible?
Concord Repatriation General Hospital
Hospital Road
Concord, , 2139
Australia
Not Recruiting --
Icon Cancer Foundation
40 Chasely Street Wesley Medical Centre Level 1
Auchenflower, , 4066
Australia
Recruiting -- Am I Eligible?
Monash Medical Centre
246 Clayton Road
Clayton, VIC, 3168
Australia
Recruiting -- Am I Eligible?
Newcastle Calvary Mater Hospital
Edith Street
Waratah, , 2298
Australia
Recruiting -- Am I Eligible?
Perth Blood Institute
18 Prowse Street
West Perth, , 6005
Australia
Recruiting -- Am I Eligible?
Royal Adelaide Hospital
Port Road
Adelaide, , 5000
Australia
Recruiting -- Am I Eligible?
The Alfred Hospital
55 Commercial Road
Melbourne, , 3004
Australia
Not Recruiting --
Wollongong Private Hospital
Crown Street Nsw Department Of Haematology
Wollongong, , 2500
Australia
Recruiting -- Am I Eligible?

More about study participation.

Participation in the study lasts approximately six years (and may be shorter or longer for certain participants). This includes: 

  • a screening period of approximately 35 days,
  • an initial 24-week treatment period (which may be extended if certain criteria are met and if you continue to benefit from the treatment), and
  • a follow-up period where you will be contacted approximately every 12 weeks to ask how you are doing (follow up on progress). 

The study drug being used in the COMMANDS Trial is is a protein that aims to help increase the production of red blood cells in bone marrow. The study drug will be administered as an injection every three weeks during the treatment period.